The relationship between pharma and the NHS is challenging, not cosy
The three-cornered partnership between the NHS, pharma and academic medicine can only benefit from a more open culture, says Timothy Evans.
Continue reading this article – simply subscribe below
Subscribing takes two minutes and you’ll immediately have full access to hsj.co.uk, plus the HSJ magazine delivered every week.







